跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
NOUMED MIRTAZAPINE mirtazapine 30 mg tablet blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
NOUMED MIRTAZAPINE mirtazapine 30 mg tablet blister pack
Approved
STANDARD
NOUMED MIRTAZAPINE mirtazapine 30 mg tablet blister pack
Avallon Pharmaceuticals Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
722996d69c8d2e1b
Company
Avallon Pharmaceuticals Pty Ltd
Type
Standard
Approval Details
Approval Id
722996d69c8d2e1b
Product Name
NOUMED MIRTAZAPINE mirtazapine 30 mg tablet blister pack
Artg Id
308469
Artg Name
NOUMED MIRTAZAPINE mirtazapine 30 mg tablet blister pack
Sponsor
Avallon Pharmaceuticals Pty Ltd
Company Detail Path
/organization/avallon-pharmaceuticals-pty-limited
Artg Date
2018-11-07
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/8d43819444ec4fdecc2217cc57f41bf4.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/a62a0914b1d9b1f5f74b3d39c9228cec.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
722996d69c8d2e1b
Type
Standard
Back to TGA Approvals